Analyst Frank Morgan works at RBC and is focused on the Healthcare sector with 698 price targets and ratings documented since 2009 spanning on 30 stocks. Analyst's average stock valuation to be materialised ratio is 67.92% with an average time for price targets to be met of 341.63 days.
Most recent stock forecast was given on AMED, Amedisys, Inc at 31-Oct-2022.
Frank Morgan best performing recommendations are on SLQT (SELECTQUOTE INC).
The best stock recommendation documented was for AMED (AMEDISYS, INC) at 3/8/2012. The price target of $13 was fulfilled within 1 day with a profit of $0.63 (5.09%) receiving and performance score of 50.93.
Average potential price target upside